ES2948510T3 - Actividad antibacteriana de galactooligosacárido y xilitol en tratamientos dermatológicos - Google Patents

Actividad antibacteriana de galactooligosacárido y xilitol en tratamientos dermatológicos Download PDF

Info

Publication number
ES2948510T3
ES2948510T3 ES18737197T ES18737197T ES2948510T3 ES 2948510 T3 ES2948510 T3 ES 2948510T3 ES 18737197 T ES18737197 T ES 18737197T ES 18737197 T ES18737197 T ES 18737197T ES 2948510 T3 ES2948510 T3 ES 2948510T3
Authority
ES
Spain
Prior art keywords
galactooligosaccharide
formulation
xylitol
skin
topical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18737197T
Other languages
English (en)
Spanish (es)
Inventor
Andrea Zanardi
Alessandra Ceraci
Ivan Montaldo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rottapharm SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm SpA filed Critical Rottapharm SpA
Application granted granted Critical
Publication of ES2948510T3 publication Critical patent/ES2948510T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES18737197T 2017-06-27 2018-06-27 Actividad antibacteriana de galactooligosacárido y xilitol en tratamientos dermatológicos Active ES2948510T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762525489P 2017-06-27 2017-06-27
PCT/EP2018/067337 WO2019002421A1 (en) 2017-06-27 2018-06-27 ANTIBACTERIAL ACTIVITY OF GALACTO-OLIGOSACCHARIDE AND XYLITOL IN DERMATOLOGICAL TREATMENTS

Publications (1)

Publication Number Publication Date
ES2948510T3 true ES2948510T3 (es) 2023-09-13

Family

ID=62816525

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18737197T Active ES2948510T3 (es) 2017-06-27 2018-06-27 Actividad antibacteriana de galactooligosacárido y xilitol en tratamientos dermatológicos

Country Status (12)

Country Link
US (1) US11234997B2 (cg-RX-API-DMAC7.html)
EP (2) EP4241855A3 (cg-RX-API-DMAC7.html)
JP (1) JP7170002B2 (cg-RX-API-DMAC7.html)
KR (1) KR102675209B1 (cg-RX-API-DMAC7.html)
AU (1) AU2018293307B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019027089B1 (cg-RX-API-DMAC7.html)
ES (1) ES2948510T3 (cg-RX-API-DMAC7.html)
MY (1) MY203497A (cg-RX-API-DMAC7.html)
NZ (1) NZ759173A (cg-RX-API-DMAC7.html)
PH (1) PH12019502874A1 (cg-RX-API-DMAC7.html)
SA (1) SA519410993B1 (cg-RX-API-DMAC7.html)
WO (1) WO2019002421A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201900031D0 (en) * 2019-01-02 2019-02-13 Rottapharm Spa Antibacterial oral compositions
GB201911071D0 (en) * 2019-08-02 2019-09-18 Meda Pharma S P A Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment
MX2022010412A (es) * 2020-02-25 2022-09-07 Unilever Ip Holdings B V Uso de una combinacion de un sacarido y glicerol para beneficios prebioticos.
DE102020133860A1 (de) 2020-12-16 2022-06-23 MNT Systeme GmbH VERWENDUNG VON β-GALAKTOOLIGOSACCHRIDEN FÜR DIE HERSTELLUNG EINER KOSMETISCHEN UND/ODER PHARMAKOLOGISCH WIRKSAMEN ZUSAMMENSETZUNG
JP2022102000A (ja) * 2020-12-25 2022-07-07 物産フードサイエンス株式会社 吸血昆虫の誘引抑制剤および吸血昆虫誘引菌の菌数抑制剤
WO2022230925A1 (ja) * 2021-04-28 2022-11-03 アスパック企業株式会社 膿皮症改善剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
JP2000302673A (ja) * 1999-04-22 2000-10-31 Shiseido Co Ltd アトピー性皮膚炎用皮膚外用剤
JP4011787B2 (ja) * 1999-04-22 2007-11-21 株式会社資生堂 選択的抗菌組成物
JP2002302404A (ja) * 2001-04-02 2002-10-18 Shiseido Co Ltd 抗菌防黴助剤
JP2008156308A (ja) * 2006-12-26 2008-07-10 Lion Corp 口腔用組成物
JP5207664B2 (ja) * 2007-06-04 2013-06-12 株式会社シャネル化粧品技術開発研究所 化粧品
CN104105471B (zh) 2012-02-14 2018-03-13 宝洁公司 皮肤共生益生元剂和包含其的组合物的局部使用
CN103462881B (zh) * 2013-10-10 2016-06-22 深圳市容大生物技术有限公司 一种可促进皮肤微生态平衡的组合物及其制备方法
JP2016196435A (ja) * 2015-04-06 2016-11-24 コーベビオケミア株式会社 スキンケア用組成物
CN104970176A (zh) 2015-07-02 2015-10-14 广州普正生物科技有限公司 复合真菌多糖凝胶糖果
CN105796377A (zh) * 2016-03-18 2016-07-27 西安膳方医药科技有限公司 一种通过微生态调整改善生物体表健康的方法
JP2019515886A (ja) * 2016-03-31 2019-06-13 ゴジョ・インダストリーズ・インコーポレイテッド 病原体結合を減少させるための局所用組成物
CN106071033A (zh) * 2016-05-12 2016-11-09 南京泽朗生物科技有限公司 一种含益生元的冰激凌及其制备方法
CN106616602A (zh) * 2016-12-09 2017-05-10 宁夏沃福百瑞枸杞产业股份有限公司 一种黑枸杞益生菌片的制备方法

Also Published As

Publication number Publication date
EP4241855A3 (en) 2023-10-25
SA519410993B1 (ar) 2023-10-16
RU2020102673A (ru) 2021-07-27
EP3644945A1 (en) 2020-05-06
JP2020525460A (ja) 2020-08-27
AU2018293307A1 (en) 2019-12-05
US20200171070A1 (en) 2020-06-04
EP4241855A2 (en) 2023-09-13
KR102675209B1 (ko) 2024-06-17
AU2018293307B2 (en) 2023-09-21
BR112019027089B1 (pt) 2023-04-25
JP7170002B2 (ja) 2022-11-11
MY203497A (en) 2024-06-30
NZ759173A (en) 2022-11-25
WO2019002421A1 (en) 2019-01-03
EP3644945B1 (en) 2023-06-07
RU2020102673A3 (cg-RX-API-DMAC7.html) 2021-09-10
KR20200024786A (ko) 2020-03-09
US11234997B2 (en) 2022-02-01
BR112019027089A2 (pt) 2020-07-07
EP3644945C0 (en) 2023-06-07
PH12019502874A1 (en) 2020-10-05

Similar Documents

Publication Publication Date Title
JP7170002B2 (ja) 皮膚科治療におけるガラクトオリゴ糖およびキシリトールの抗菌活性
JP5106109B2 (ja) コラーゲン産生増強剤とその用途
KR102132544B1 (ko) 활성 성분들을 위한 페트롤라툼-계 전달 시스템
EP4007569A1 (en) Combinations of oligosaccharides and xylitol for dermatological treatment
CN107405370B (zh) 含有Lactococcus chungangensis作为有效成分的用于预防或治疗炎性疾病的药物组合物
US20200383898A1 (en) Topical composition and related methods
JP6468559B2 (ja) 動物用の口腔用組成物並びにそれを使用した動物用の歯周病予防剤及び動物用の口臭予防剤
US11413305B2 (en) Use of agar-derived oligosaccharides for inhibiting growth of Staphylococcus
KR20230131879A (ko) 단쇄 프럭토올리고당 및 천연 전분을 기반으로 한 화장방법 및 조성물
CN117098527A (zh) 基于短链低聚果糖和天然淀粉的美容方法和组合物
JP2014166992A (ja) 口腔用組成物
RU2780618C2 (ru) Антибактериальная активность галактоолигосахарида и ксилита в дерматологических лечениях
WO2020141201A1 (en) Antibacterial oral compositions
HK40021213B (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
HK40021213A (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
KR101929565B1 (ko) 복분자 추출물을 함유하는 바이오필름 형성 억제용 조성물
WO2019079150A1 (en) COMPOSITIONS AND METHODS FOR TREATING ATOPIC DERMATITIS
JP2018016594A (ja) 動物用皮膚外用剤
Fatima et al. Sophorolipid: A Glycolipid Biosurfactant Applications in Therapeutics and Cosmetics
JP2024127663A (ja) 皮膚の短鎖脂肪酸生成促進剤
CN120284804A (zh) 一种抑菌去屑控油舒缓抗敏组合物及其应用